Form 8-K - Current report:
SEC Accession No. 0001193125-24-233897
Filing Date
2024-10-07
Accepted
2024-10-07 17:24:33
Documents
15
Period of Report
2024-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d900238d8k.htm   iXBRL 8-K 26895
2 EX-10.1 d900238dex101.htm EX-10.1 17580
  Complete submission text file 0001193125-24-233897.txt   209265

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sclxw-20241002.xsd EX-101.SCH 3910
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sclxw-20241002_def.xml EX-101.DEF 13700
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sclxw-20241002_lab.xml EX-101.LAB 22562
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sclxw-20241002_pre.xml EX-101.PRE 14669
18 EXTRACTED XBRL INSTANCE DOCUMENT d900238d8k_htm.xml XML 5696
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 241358665
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)